Results 231 to 240 of about 124,409 (322)

Gut Microbial Variations Associated With Proton Pump Inhibitor Use in the Boston Puerto Rican Health Study

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Proton pump inhibitors (PPI), used to treat gastrointestinal disorders, are associated with alterations in the gut microbiome. However, this is understudied in Puerto Ricans who have unique lifestyle characteristics. Puerto Ricans, including participants of the Boston‐Puerto Rican Health Study (BPRHS), report high PPI use.
Deepika Dinesh, Xochitl C. Morgan, Hanseul Kim, Tammy M. Scott, Mahdi Garelnabi, Jong Soo Lee, Kelsey M. Mangano, Long H. Nguyen, Curtis Huttenhower, Katherine L. Tucker, Natalia Palacios   +10 more
wiley   +1 more source

Association of gastroesophageal reflux disease with small intestinal bacterial overgrowth: a case-control study. [PDF]

BMC Gastroenterol
Hu Z, Shan B, Wang Y, Yang J, Lu L, Wang Y, Pang X.   +6 more
europepmc   +1 more source

High Rates of Defect Closure After Resection of Large Nonpedunculated Colorectal Lesions Using a Through‐The‐Scope Clip With Anchor Prongs

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Prophylactic complete closure of mucosal defects after resection of gastrointestinal lesions is key to reducing delayed bleeding, but complete closure for large defects can be challenging with conventional through‐the‐scope clips (TTSC).
Daniel von Renteln, Douglas K. Rex, Heiko Pohl, Nikhil A. Kumta, Shannon Chan, Marvin Ryou, Zaheer Nabi, Ping Hong Zhou, Haruhiro Inoue, Joyce A. Peetermans, Matthew J. Rousseau, Jeffrey D. Mosko   +11 more
wiley   +1 more source

The Need for Objective Testing in Proton Pump Inhibitor-refractory Extraesophageal Gastroesophageal Reflux Disease. [PDF]

J Neurogastroenterol Motil
Kim SY.
europepmc   +1 more source

Neurobiology of relaxation training in gastroesophageal reflux disease

, 1995
Ernest H. Friedman
openalex   +1 more source

Mechanisms of Action Involved in the In Vivo Gastroprotective Response of Fruits: A Systematic Review

Food Frontiers, Volume 7, Issue 1, January 2026.
ABSTRACT Gastrointestinal diseases remain a significant global health concern, primarily due to the limitations of current pharmacological treatments, which often come with adverse side effects and high recurrence rates. This situation highlights the urgent need for safer and more effective alternatives.
Isabel Sousa Alcântara, Renata Torres Pessoa, Lucas Yure Santos da Silva, Tarcisio Mendes Silva, Isis Oliveira Menezes, Anita Oliveira Brito Pereira Bezerra Martins, Irwin Rose Alencar de Menezes, Almir Gonçalves Wanderley   +7 more
wiley   +1 more source

Vonoprazan Therapy in Gastroesophageal Reflux Disease (GERD): Effects on the Severity and Frequency of GERD in Relation to Hiatus Hernia. [PDF]

Cureus
Ur Rehman A, Khan MS, Iltaf M, Ahmad W, Jan N.   +4 more
europepmc   +1 more source

Clinical and medical history aspects of gastroesophageal reflux disease with regard to the patient’s dental status

, 2015
Yu. I. Bondarenko, V. Ya. Lobanets, I. Yo. Niverovskyi, V. I. Chernetskyi   +3 more
openalex   +2 more sources

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015

Journal of gastroenterology, 2016
K. Iwakiri, Y. Kinoshita, Y. Habu, T. Oshima, N. Manabe, Y. Fujiwara, A. Nagahara, O. Kawamura, R. Iwakiri, S. Ozawa, K. Ashida, S. Ohara, H. Kashiwagi, K. Adachi, K. Higuchi, H. Miwa, K. Fujimoto, M. Kusano, Y. Hoshihara, T. Kawano, K. Haruma, M. Hongo, K. Sugano, Mamoru Watanabe, T. Shimosegawa   +24 more
semanticscholar   +1 more source

A Rational Approach to Pharmacotherapy in Pregnancy

The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Most pregnant individuals are exposed to at least one medication, whether prescription or over the counter, during pregnancy. Despite the ubiquity of medication use in pregnancy, there remains no standardized framework to guide clinicians in selecting the most appropriate pharmacotherapy that balances maternal needs with fetal safety. This gap
Gregory W. Kirschen, Kevin Watt, Ahizechukwu C. Eke   +2 more
wiley   +1 more source